Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC)

References

• World Health Organization. Diabetes factsheet. Geneva: WHO, 2012.
   Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14.
   PubMed Web of Science ®Google Scholar
• Zheng YF, He MG, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012;60:428–431.
   PubMed Web of Science ®Google Scholar
• Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–564.
   PubMed Web of Science ®Google Scholar
• Ciulla TA. Epidemiology and impact of diabetic retinopathy. Adv Stud Med 2004;4:694–701.
   Google Scholar
• Ola MS, Nawaz MI, Siddiquei MM, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications 2012;26:56–64.
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Dixon Z, et al. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 2000;71:239–245.
   PubMed Web of Science ®Google Scholar
• Hozawa A, Jacobs DR, Steffes MW, et al. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA)/ Young Adult Longitudinal Trends in Antioxidants (YALTA) Study. Clin Chem 2007;53:447–455.
   PubMed Web of Science ®Google Scholar
• Kim JE, Clark RM, Park Y, et al. Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr Res Pract 2012;6:113–119.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008;49:1645–1651.
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram R, Selvaraj RK. Lutein supplementation alters inflammatory cytokine production and antioxidant status in F-line turkeys. Poult Sci 2011;90:971–976.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kanwar M, Chan PS, et al. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch Ophthalmol 2008;126:1266–1272.
   PubMedGoogle Scholar
• Tian Y, Kijlstra A, Van der Veen RLP, et al. The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. Plos One 2013;8(8).
   Google Scholar
• Beatty S, Koh HH, Henson D, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115–134.
   PubMed Web of Science ®Google Scholar
• Mares JA, Millen AE. Meyers KJ. Diet and supplements in the prevention and treatment of eye diseases. In: Coulston AM, Boushey CJ, Ferruzzi MG, eds. Nutrition in the prevention and treatment of disease, Chapter 19, 3rd ed. London: Elsevier Academic Press, 2013, 341–371.
   Google Scholar
• Hu BJ, Hu YN, Lin S, et al. Application of lutein and zeaxanthin nonproliferative diabetic retinopathy. Intl J Ophthalmol 2011;4:303–306.
   PubMed Web of Science ®Google Scholar
• Brazionis L, Rowley K, Itsiopoulos C, et al. Plasma carotenoids and diabetic retinopathy. Br J Nutr 2009;101:270–277.
   PubMed Web of Science ®Google Scholar
• Garcia-Medina JJ, Pinazo-Duran MD, Garcia-Medina M, et al. A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy. Eur J Ophthalmol 2011;21:637–643.
   PubMed Web of Science ®Google Scholar
• Atherosclerosis Risk in Communities (ARIC) Study Research Group. Response Rate for Annual Follow Up (AFU) CY2‐CY23 AFU Versions A‐M, V1. Chapel Hill, NC: Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, 2012.
   Google Scholar
• The ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) Study – design and objectives. Am J Epidemiol 1989;129:687–702.
   PubMed Web of Science ®Google Scholar
• Atherosclerosis Risk in Communities (ARIC) Study Research Group. Manual 2 – Cohort component procedures, version 2.0. Chapel Hill, NC: The ARIC Coordinating Center, 1988.
   Google Scholar
• Atherosclerosis Risk in Communities (ARIC) Study Research Group. Exam 3 Derived variable dictionary, version 37. Atherosclerosis Risk in Communities (ARIC) Study Research Group, 2010; v. 2012.
   Google Scholar
• Atherosclerosis Risk in Communities (ARIC) Study Research Group. ARIC Data Book, Cohort, Exam 1 TOTNUTX nutritional data. Chapel Hill, NC: Collaborative Studies Coordinating Center, Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
   Google Scholar
• Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51–65.
   PubMed Web of Science ®Google Scholar
• Stevens J, Metcalf PA, Dennis BH, et al. Reliability of a food frequency questionnaire by ethnicity, gender, age and education. Nutr Res 1996;16:735–745.
   Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531–540.
   PubMed Web of Science ®Google Scholar
• Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study. Ophthalmology 1999;106:2269–2280.
   PubMed Web of Science ®Google Scholar
• Fundus photographic risk-factors for progression of diabetic-retinopathy – ETDRS report number-12. Ophthalmology 1991;98:823–833.
   Google Scholar
• Atherosclerosis Risk in Communities (ARIC) Study Research Group. Manual 7. Blood collection. Chapel Hill, NC: Atherosclerosis Risk in Communities (ARIC) Study Research Group, 1988.
   Google Scholar
• Folsom AR, Szklo M, Stevens J, et al. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes – The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 1997;20:935–942.
   PubMed Web of Science ®Google Scholar
• Selvin E, Steffes MW, Gregg E, et al. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011;34:84–89.
   PubMed Web of Science ®Google Scholar
• Beck RW. The burgeoning public health impact of diabetes. The role of the ophthalmologist. Arch Ophthalmol 2011;129:225–229.
   PubMedGoogle Scholar
• Willett W, Simpson, L. Foods and nutrients. Nutritional epidemiology, 3rd ed. New York, NY: Oxford University Press, 2013.
   Google Scholar
• American Diabetes Association. A1C and eAG. Alexandria, VA: American Diabetes Association, 2013; v. 2014.
   Google Scholar
• Ainsworth BE, Jacobs DRJ, Leon AS, et al. Assessment of the Accuracy of Physical Activity Questionnaire Occupational Data. J Occup Environ Med 1993;35:1017–1027.
   Web of Science ®Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes-2013 Diabetes Care 2013;36:S11–S66.
   PubMed Web of Science ®Google Scholar
• Hu FB, Willett WC. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements Am J Epidemiol 1999;149:531–540.
   Google Scholar
• Willett W. Invited commentary: a further look at dietary questionnaire validation. Am J Epidemiol 2001;154:1100–1102.
   PubMed Web of Science ®Google Scholar
• Failla ML, Chitchumronchokchai C, Ferruzzi MG, et al. Unsaturated fatty acids promote bioaccessibility and basolateral secretion of carotenoids and alpha-tocopherol by Caco-2 cells. Food Function 2014;5:1101–1112.
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons TE, Sangiovanni JP, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 2014;132:142–149.
   PubMed Web of Science ®Google Scholar
• Millen AE, Gruber M, Klein R, et al. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003;158:225–233.
   PubMed Web of Science ®Google Scholar
• Millen AE, Klein R, Folsom AR, et al. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2004;79:865–873.
   PubMed Web of Science ®Google Scholar
• Li Z-Z, Lu X-Z, Ma C-C, et al. Serum lycopene levels in patients with diabetic retinopathy. Eur J Ophthalmol 2010;20:719–723.
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes – Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002;25:1919–1927.
   PubMed Web of Science ®Google Scholar
• Mayer-Davis EJ, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and diabetic retinopathy – The San Luis Valley Diabetes Study. Ophthalmology 1998;105:2264–2270.
   PubMed Web of Science ®Google Scholar